Health stocks Eli Lilly (LLY), United Health Group (UNH), and Merck (MRK) have recently seen positive developments, including drug approvals and strong earnings. These gains have boosted their stock prices, with LLY up over 8% YTD, UNH up 25.8% YTD, and MRK up 19.9% YTD. Investors can gain diversified exposure to these companies through healthcare ETFs like VanEck Pharmaceutical ETF (PPH), Vanguard Health Care ETF (VHT), and State Street Health Care Select Sector SPDR ETF (XLV), which have all delivered solid returns around 21-27% over the past year. These ETFs offer a way to benefit from healthcare innovation and strong sector performance amid broader market shifts.
In Q2 2026, Eli Lilly reported a strong 48% revenue growth driven by blockbuster obesity drugs Mounjaro and Zepbound, especially with rapid international expansion. Novo Nordisk faced challenges including shrinking U.S. sales, price cuts, layoffs, an...
Vanguard Growth Index Fund Admiral Shares (VIGAX) is heavily concentrated, with about 44.6% of its assets in just four mega-cap tech stocks: NVIDIA, Apple, Alphabet, and Microsoft. This concentration means investors are effectively making a large bet...
Eli Lilly projects fiscal 2026 revenue between $85 billion and $87 billion, nearing the $100 billion mark. The company's stock is up nearly 78% over the past year, driven by strong Q2 2026 results including $22.97 billion revenue and significant sale...
The FDA has approved a new blood test developed by Roche and Eli Lilly to help identify Alzheimer's disease symptoms in patients over 55. The Elecsys Phospho-Tau (217P) Plasma test detects amyloid pathology, a brain marker linked to Alzheimer's, usin...
Eli Lilly has introduced Foundayo, an oral GLP-1 pill for weight loss and type 2 diabetes, in UK pharmacies following recent approval. This tablet offers a convenient alternative to injections and is licensed for adults with certain BMI criteria or w...
